Cargando…
Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials
In clinical trials with the objective to evaluate the treatment effect on time to recovery, such as investigational trials on therapies for COVID-19 hospitalized patients, the patients may face a mortality risk that competes with the opportunity to recover (e.g., be discharged from the hospital). Th...
Autores principales: | Li, Hong, Gleason, Kevin J., Hu, Yiran, Lovell, Sandra S., Mukhopadhyay, Saurabh, Wang, Li, Huang, Bidan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986229/ https://www.ncbi.nlm.nih.gov/pubmed/35398251 http://dx.doi.org/10.1016/j.cct.2022.106758 |
Ejemplares similares
-
Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022) -
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study
por: Rehal, Sunita, et al.
Publicado: (2023) -
Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022) -
Intercurrent events in clinical research: the norm, not the exception
por: Rojas-Saunero, L. Paloma, et al.
Publicado: (2022) -
Cerebral Meningitis (Intercurrent)
por: Hay, Walter
Publicado: (1875)